Chengdu Baiyu Pharmaceuticals Co., Ltd. (hereinafter referred to as “Baiyu”) received a registration certificate for Ginkgolide Injection from the Ministry of Health of Azerbaijan in September 2025. This marks the qualification of Baiyu's Ginkgolide Injection for market launch and sales in Azerbaijan. As the first overseas approval for this product, it will positively impact the company's expansion into West Asia and Central Asia markets!